Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-13

Clinical Trial Update: Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial [Phase 2]

View source ↗

Summary

Phase 2 trial on catheter-related thromboprophylaxis with enoxaparin (CRETE) in deep venous thrombosis was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Yale University | Conditions: Deep Venous Thrombosis | Phase 2 | Status: TERMINATED | Results posted: 2020-07-13